- Home
- NIXX vs ARTV Comparison
NIXX vs ARTV Comparison
Compare NIXX & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIXX
- ARTV
- Stock Information
- Founded
- NIXX 2010
- ARTV 2019
- Country
- NIXX United States
- ARTV United States
- Employees
- NIXX N/A
- ARTV N/A
- Industry
- NIXX
- ARTV
- Sector
- NIXX
- ARTV
- Exchange
- NIXX NYSE
- ARTV NYSE
- Market Cap
- NIXX 39.8M
- ARTV 39.0M
- IPO Year
- NIXX N/A
- ARTV 2024
- Fundamental
- Price
- NIXX $2.39
- ARTV $1.61
- Analyst Decision
- NIXX
- ARTV Strong Buy
- Analyst Count
- NIXX 0
- ARTV 8
- Target Price
- NIXX N/A
- ARTV $18.14
- AVG Volume (30 Days)
- NIXX 370.6K
- ARTV 302.9K
- Earning Date
- NIXX 08-13-2025
- ARTV 05-08-2025
- Dividend Yield
- NIXX N/A
- ARTV N/A
- EPS Growth
- NIXX N/A
- ARTV N/A
- EPS
- NIXX N/A
- ARTV N/A
- Revenue
- NIXX $1,786,387.00
- ARTV N/A
- Revenue This Year
- NIXX N/A
- ARTV N/A
- Revenue Next Year
- NIXX N/A
- ARTV N/A
- P/E Ratio
- NIXX N/A
- ARTV N/A
- Revenue Growth
- NIXX 54.16
- ARTV N/A
- 52 Week Low
- NIXX $1.35
- ARTV $1.47
- 52 Week High
- NIXX $8.50
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- NIXX N/A
- ARTV N/A
- Support Level
- NIXX N/A
- ARTV N/A
- Resistance Level
- NIXX N/A
- ARTV N/A
- Average True Range (ATR)
- NIXX 0.00
- ARTV 0.00
- MACD
- NIXX 0.00
- ARTV 0.00
- Stochastic Oscillator
- NIXX 0.00
- ARTV 0.00
About NIXX NIXXY INC
Nixxy Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.Recently, the Company acquired the license from GoLogiq, Inc. (GoLogiq), to operate its fintech technology (the GOLQ Technology) and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products.. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).